186 related articles for article (PubMed ID: 16690778)
41. A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.
Sherman JH; Redpath GT; Redick JA; Purow BW; Laws ER; Jane JA; Shaffrey ME; Hussaini IM
J Neurosci Methods; 2011 May; 198(1):99-102. PubMed ID: 21402102
[TBL] [Abstract][Full Text] [Related]
42. Prospective characterization of neural stem cells by flow cytometry analysis using a combination of surface markers.
Nagato M; Heike T; Kato T; Yamanaka Y; Yoshimoto M; Shimazaki T; Okano H; Nakahata T
J Neurosci Res; 2005 May; 80(4):456-66. PubMed ID: 15795928
[TBL] [Abstract][Full Text] [Related]
43. In vitro characterization of CD133
Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
[TBL] [Abstract][Full Text] [Related]
44. AC133-2, a novel isoform of human AC133 stem cell antigen.
Yu Y; Flint A; Dvorin EL; Bischoff J
J Biol Chem; 2002 Jun; 277(23):20711-6. PubMed ID: 12042327
[TBL] [Abstract][Full Text] [Related]
45. Regeneration of irradiated salivary glands with stem cell marker expressing cells.
Nanduri LS; Maimets M; Pringle SA; van der Zwaag M; van Os RP; Coppes RP
Radiother Oncol; 2011 Jun; 99(3):367-72. PubMed ID: 21719134
[TBL] [Abstract][Full Text] [Related]
46. Convenient and efficient enrichment of the CD133+ liver cells from rat fetal liver cells as a source of liver stem/progenitor cells.
Liu WH; Li R; Dou KF
Stem Cell Rev Rep; 2011 Mar; 7(1):94-102. PubMed ID: 20180050
[TBL] [Abstract][Full Text] [Related]
47. CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines.
Sana J; Zambo I; Skoda J; Neradil J; Chlapek P; Hermanova M; Mudry P; Vasikova A; Zitterbart K; Hampl A; Sterba J; Veselska R
Anal Cell Pathol (Amst); 2011; 34(6):303-18. PubMed ID: 22156015
[TBL] [Abstract][Full Text] [Related]
48. Purification of mouse bone marrow-derived stem cells promotes ex vivo neuronal differentiation.
Jamous M; Al-Zoubi A; Khabaz MN; Khaledi R; Al Khateeb M; Al-Zoubi Z
Cell Transplant; 2010; 19(2):193-202. PubMed ID: 20350359
[TBL] [Abstract][Full Text] [Related]
49. Limits of CD133 as a marker of glioma self-renewing cells.
Clément V; Dutoit V; Marino D; Dietrich PY; Radovanovic I
Int J Cancer; 2009 Jul; 125(1):244-8. PubMed ID: 19350631
[TBL] [Abstract][Full Text] [Related]
50. CD45+/CD133+ positive cells expanded from umbilical cord blood expressing PDX-1 and markers of pluripotency.
Pessina A; Bonomi A; Sisto F; Baglio C; Cavicchini L; Ciusani E; Coccé V; Gribaldo L
Cell Biol Int; 2010 Aug; 34(8):783-90. PubMed ID: 20397976
[TBL] [Abstract][Full Text] [Related]
51. Cell surface Nestin is a biomarker for glioma stem cells.
Jin X; Jin X; Jung JE; Beck S; Kim H
Biochem Biophys Res Commun; 2013 Apr; 433(4):496-501. PubMed ID: 23524267
[TBL] [Abstract][Full Text] [Related]
52. New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133).
Bauer N; Fonseca AV; Florek M; Freund D; Jászai J; Bornhäuser M; Fargeas CA; Corbeil D
Cells Tissues Organs; 2008; 188(1-2):127-38. PubMed ID: 18160824
[TBL] [Abstract][Full Text] [Related]
53. Identification of an interaction between the m-band protein skelemin and beta-integrin subunits. Colocalization of a skelemin-like protein with beta1- and beta3-integrins in non-muscle cells.
Reddy KB; Gascard P; Price MG; Negrescu EV; Fox JE
J Biol Chem; 1998 Dec; 273(52):35039-47. PubMed ID: 9857037
[TBL] [Abstract][Full Text] [Related]
54. Expression of neuronal markers in differentiated marrow stromal cells and CD133+ stem-like cells.
Padovan CS; Jahn K; Birnbaum T; Reich P; Sostak P; Strupp M; Straube A
Cell Transplant; 2003; 12(8):839-48. PubMed ID: 14763503
[TBL] [Abstract][Full Text] [Related]
55. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
[TBL] [Abstract][Full Text] [Related]
56. Expression of CD133 and other putative stem cell markers in uveal melanoma.
Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
[TBL] [Abstract][Full Text] [Related]
57. Convenient and efficient enrichment of the CD133+ liver cells from rat fetal liver as a source of liver stem/progenitor cells.
Liu W; You N; Dou K
Methods Mol Biol; 2012; 879():135-46. PubMed ID: 22610558
[TBL] [Abstract][Full Text] [Related]
58. Alpha1 and beta1 integrins enhance the homing and differentiation of cultured prostate cancer stem cells.
Rentala S; Yalavarthy PD; Mangamoori LN
Asian J Androl; 2010 Jul; 12(4):548-55. PubMed ID: 20531279
[TBL] [Abstract][Full Text] [Related]
59. High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells.
Ni HT; Hu S; Sheng WS; Olson JM; Cheeran MC; Chan AS; Lokensgard JR; Peterson PK
Brain Res Dev Brain Res; 2004 Sep; 152(2):159-69. PubMed ID: 15351504
[TBL] [Abstract][Full Text] [Related]
60. Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells.
Schwab KE; Hutchinson P; Gargett CE
Hum Reprod; 2008 Apr; 23(4):934-43. PubMed ID: 18305000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
